Výsledky vyhledávání - "Christoph Hoener zu Siederdissen"

Predictors of HBsAg loss after cessation of nucleo (s)tide analogue therapy in asian patients with low HBsAg levels

Publikováno v: Journal of Hepatology. 77:S824-S825

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c7e6ca71e6e4b55a6c0fcc7ab90f3e2e
https://doi.org/10.1016/s0168-8278(22)01946-8

Zobrazit plný text záznamu

Limited value of HBV-RNA levels for the prediction of relapse after discontinuation of nucleos (t)ide analogue therapy in HBe antigen negative chronic hepatitis B patients

Autor: Valerie Ohlendorf, Maximilian Wübbolding, Christoph Hoener zu Siederdissen, Birgit Bremer, Katja Deterding, Heiner Wedemeyer, Markus Cornberg, Benjamin Maasoumy

Publikováno v: Journal of Hepatology. 77:S248-S249

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d1f89faf5547a971b6b9d393f7d7f0c3
https://doi.org/10.1016/s0168-8278(22)00867-4

Zobrazit plný text záznamu

Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications

Autor: Ceyhun Bicer, Maria Beumont-Mauviel, Markus Cornberg, Sivi Ouwerkerk-Mahadevan, David Back, Saye Khoo, Fiona Marra, M. Schlag, W. Jessner, Christoph Hoener zu Siederdissen, I. Lonjon-Domanec, R. Kalmeijer

Publikováno v: British Journal of Clinical Pharmacology. 84:961-971

Aims Direct-acting antiviral agents (DAAs) for the treatment of hepatitis C (HCV) can be associated with drug-drug interactions (DDIs) with concomitant medications. The practical clinical implications of such DDIs are poorly understood. We assessed t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5b8be15046ffb74acd93e39900e5c9ef
https://doi.org/10.1111/bcp.13519

Zobrazit plný text záznamu

Low HBcrAg and HBsAg levels identify patients most likely to achieve sustained response after nucleos(t)ide analogue cessation: results from a global individual patient data meta-analysis (create study)

Autor: Milan Sonneveld, Jun Yong Park, Wai-Kay Seto, Yasuhito Tanaka, Ivana Carey, Margarita Papatheodoridi, Fabien Zoulim, Sang Hoon Ahn, George Dalekos, Christoph Hoener zu Siederdissen, Markus Cornberg, Man-Fung Yuen, Kosh Agarwal, Andre Boonstra, Maria Buti, George Papatheodoridis, Benjamin Maasoumy

Publikováno v: Journal of Hepatology. 73:S873-S874

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cb8b1f647f8636a52e47c6b832ea45a6
https://doi.org/10.1016/s0168-8278(20)32189-9

Zobrazit plný text záznamu

Machine learning identifies immune profile to predict virological relapse after stopping nucleos(t)ide analogue therapy in HBeAg negative chronic hepatitis B

Autor: Maximilian Wübbolding, Juan Carlos Lopez Alfonso, Sebastian Binder, Christine Falk, Jennifer Debarry, Paul Gineste, Anke Kraft, Michael P. Manns, Benjamin Maasoumy, Heiner Wedemeyer, Michael Meyer-Hermann, Markus Cornberg, Christoph Hoener zu Siederdissen

Publikováno v: Journal of Hepatology. 73:S603-S604

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b559ed34e1ce1ff6af129bc3a806d8a8
https://doi.org/10.1016/s0168-8278(20)31674-3

Zobrazit plný text záznamu

THU-178-Drug-drug interactions in HCV therapy: Still relevant for clinical practice?

Autor: Christoph Hoener zu Siederdissen, Michael P. Manns, Benjamin Maasoumy, Markus Cornberg, Fiona Marra, Kerstin Port, Maximilian Wübbolding, Benjamin Schulte, David Back

Publikováno v: Journal of Hepatology. 70:e240

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::061ca2c32e1944515a719fc00d34405d
https://doi.org/10.1016/s0618-8278(19)30453-0

Zobrazit plný text záznamu

Current and Future Treatment of Chronic Hepatitis C Genotype 2 and 3

Autor: Christoph Hoener zu Siederdissen, Markus Cornberg

Publikováno v: Current Hepatitis Reports. 12:261-268

Hepatitis C genotype 2 and 3 accounts for a significant number of HCV infected patients around the world. The combination of peginterferon alpha and ribavirin (PEG-IFN/RBV) demonstrated favourable results in treatment of genotype 2 and 3 infected pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::465b469a241a9e744c9738d4601046fa
https://doi.org/10.1007/s11901-013-0191-5

Zobrazit plný text záznamu

Home-Based Management of Refractory Ascites by Permanent Tunneled Peritoneal Catheter is an Effective Replacement for Recurrent Large Volume Paracentesis

Autor: Kerstin Port, H. Wedemeyer, Elmar Jäckel, S. Ziegert, M.P. Manns, Christoph Hoener zu Siederdissen, Philipp Solbach, K. Hueper, Astrid Schneider, Richard Taubert

Publikováno v: Journal of Hepatology. 64:S655

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5ba93f610187776c4d0633a94784fa0e
https://doi.org/10.1016/s0168-8278(16)01227-7

Zobrazit plný text záznamu

The Addition of Ribavirin is Associated with a Significantly Reduced Quality of Life in Patients Treated with IFN-Free Direct-Acting Antiviral Therapy

Autor: Katja Deterding, M. Cornberg, Christoph Hoener zu Siederdissen, H. Wedemeyer, M.P. Manns, Kerstin Port

Publikováno v: Journal of Hepatology. 64:S611

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ca01517dd1c25429403c671382ed950b
https://doi.org/10.1016/s0168-8278(16)01131-4

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání